Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

In brief: otrexup--a single-use auto-injector formulation of methotrexate.

[No authors listed]

Med Lett Drugs Ther. 2014 Mar 31;56(1439):28. Review. No abstract available.

PMID:
24691150
2.

[Subcutaneous self-administration of methotrexate in rheumatoid arthritis].

Huisman AM, Schouten JP, van Paassen HC, Wouters JM, Jacobs JW.

Ned Tijdschr Geneeskd. 1996 Jul 27;140(30):1564-5. Dutch. No abstract available.

PMID:
8765767
3.

Self-injection of gold and methotrexate.

Arthur V, Jubb R, Homer D.

J Rheumatol. 2001 Jan;28(1):212. No abstract available.

4.

Limitations of the study of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: comment on the article by Braun et al.

Raghu P, Grover PS, Kumar A.

Arthritis Rheum. 2008 Jul;58(7):2209; author reply 2209-10. doi: 10.1002/art.23615. No abstract available.

5.

Subcutaneous methotrexate is well tolerated and superior to oral methotrexate in the treatment of rheumatoid arthritis.

Hameed B, Jones H.

Int J Rheum Dis. 2010 Oct;13(4):e83-4. doi: 10.1111/j.1756-185X.2010.01482.x. No abstract available.

PMID:
21199461
6.

Bioavailability of higher dose MTX comparing oral and subcutaneous administration in patients with RA.

Rau R.

J Rheumatol. 2005 Jul;32(7):1412; author reply 1412-3. No abstract available.

7.

Therapy: oral or subcutaneous methotrexate for rheumatoid arthritis?

Alsaeedi S, Keystone EC.

Nat Rev Rheumatol. 2014 Oct;10(10):578-9. doi: 10.1038/nrrheum.2014.129. Epub 2014 Aug 5. No abstract available.

PMID:
25090946
8.

[Methotrexate: advantages of subcutaneous administration].

Kr├╝ger K.

Z Rheumatol. 2008 Jul;67(4):332-3. doi: 10.1007/s00393-008-0295-4. German. No abstract available.

PMID:
18443809
9.

Comment on: Use of parenteral methotrexate significantly reduces the need for biological therapy.

Thornton C, Ong V, Ward J, Kennedy N, Steuer A.

Rheumatology (Oxford). 2008 Sep;47(9):1438; author reply 1438. doi: 10.1093/rheumatology/ken250. Epub 2008 Jul 10. No abstract available.

PMID:
18617550
10.

Subtherapeutic dosing of methotrexate in rheumatoid arthritis trials.

Parker CT, Mewshaw E, Dennis GJ.

J Am Osteopath Assoc. 2004 Jan;104(1):7-8. No abstract available.

PMID:
14992316
11.

Rare side effects of subcutaneous methotrexate therapy.

Kapoor S.

J Rheumatol. 2013 Feb;40(2):205. doi: 10.3899/jrheum.121099. No abstract available.

PMID:
23378498
12.

Subcutaneous methotrexate to cut costs?

Hassanzadeh R, Mangan C, France J, Bawa S.

J Rheumatol. 2012 Aug;39(8):1764-5. doi: 10.3899/jrheum.120091. No abstract available.

PMID:
22859538
13.

Parenteral methotrexate should be given before biological therapy.

Griffin AJ, Erkeller-Yuksel F.

Rheumatology (Oxford). 2004 May;43(5):678; author reply 678-9. No abstract available.

PMID:
15103040
14.

Intramuscular methotrexate in inflammatory rheumatic disease.

Burbage G, Gupta R, Lim K.

Ann Rheum Dis. 2001 Dec;60(12):1156. No abstract available.

15.

Cyclosporine and methotrexate for severe rheumatoid arthritis.

Malleson P.

N Engl J Med. 1995 Dec 7;333(23):1567; author reply 1568-9. No abstract available.

PMID:
7477177
16.

Safe prescribing of methotrexate for rheumatoid arthritis.

Kirkham BW.

Med J Aust. 1995 Sep 4;163(5):278. No abstract available.

PMID:
7565224
17.

Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis.

Wassenberg S, Rau R.

J Rheumatol. 2003 Aug;30(8):1891; author reply 1891-2. No abstract available.

18.

Relapse of rheumatoid arthritis after substitution of oral for parenteral administration of methotrexate.

Rozin A, Schapira D, Balbir-Gurman A, Braun-Moscovici Y, Markovits D, Militianu D, Nahir MA.

Ann Rheum Dis. 2002 Aug;61(8):756-7. No abstract available.

19.

[Standardization of methotrexate administration in routine rheumatological practice].

Murav'ev IuV.

Ter Arkh. 2011;83(5):33-7. Review. Russian.

PMID:
21780654
20.

Optimal use of methotrexate: the advantages of tight control.

Bijlsma JW, Weinblatt ME.

Ann Rheum Dis. 2007 Nov;66(11):1409-10.

Supplemental Content

Support Center